This report is being refiled per fda request to indicate initial report type.This report is an "initial" to uf/importer report #: 3005529799-2015-00009.Contact office: (b)(4).Manufacturer name/address: (b)(4).Date received by manufacturer: 20-jul-2015.510k: k071132.Adverse event: follow-up # 1.Type of event: malfunction follow up: correction, additional information.Adverse event codes: (b)(4).Device usage: reuse.Additional information: the most probable cause of the abnormal peaks is related to the extended column life beyond 2500 injections.Review of the g8 variant analysis mode training manual informs the user of the following: columns are warranted for 2500 injections.After column replacement, use the column reset key to reset the column count.Flag 06 may be programmed to alert the operator after 2500 injections are performed with a specific column.When the flag for number of injections is programmed, every specimen that exceeds the limit will be printed with the flag.Tosoh bioscience, inc.Is submitting on behalf of the foreign manufacturer, tosoh corporation, per exemption number e2017013.This report is being submitted due to a retrospective review conducted under capa(b)(4).
|
On 20jul-2015, tosoh bioscience, inc.Was notified of erroneous patient hba1c results that were reported on 25-jun-2015.The testing was done on a tosoh hplc g8 analyzer, and all quality controls were within acceptable target ranges.Chromatograms were reviewed after the results were reported and it was discovered that the chromatogram peaks looked abnormal and test results should not have been reported.The column count at the time of this event was 3800, and required replacement.Following replacement of the column, calibration was performed and quality controls run.Quality controls were within acceptable range (level 1 result: 6.3, acceptable range: 5.66 - 6.86; level 2 result: 9.4, acceptable range: 8.37 - 9.94), and the chromatogram peaks looked normal.Of the 200 patient results reviewed with abnormal looking chromatograms, approximately 43 specimens in the range of 7.0- to 7.9 were repeated following installation of the new column.The repeated specimen results were lower, and corrected patient results were reported to the ordering physicians.
|